Niederer Kraft Frey (NKF) advised private equity firm EOS Partners on the acquisition of a majority stake in Flexicode and Flexicode Schweiz. The parties Headquartered in Munich, EOS Partners manages EUR 500 million in AUM, focusing
Baker McKenzie advised Swiss medical regeneration technologies specialist Geistlich Pharma (Geistlich) on its acquisition of a minority stake in TRI Dental Implants (TRI), a provider of digital implant solutions which developed an abutment-free dental implant
Bär & Karrer advised GRO, a private equity firm with a specific focus on software companies in Northern Europe, throughout completion of a follow-on investment in Akselos, a structural performance management (SPM) software specialist
Welcome to our weekly newsletter appointment with Signed, Sealed, Weekend. Let’s go through the news highlights of week, which is now coming to an end. Orrick has confirmed to legalcommunity.ch that it will
Bär & Karrer advised DBAG Fund VII on the sale of duagon Group – a Dietikon-based provider of communication, control, and computer technology for applications in the railway and transportation industries – to Knorr-Bremse Group. The
Niederer Kraft Frey (NKF) advised a banking syndicate consisting of UBS London Branch, BNP Paribas, Citigroup Global Markets Europe, HSBC Continental Europe, Crédit Industriel et Commercial, J.P. Morgan, and Société Géné
Homburger advised Santhera in connection with its CHF 20 m royalty monetization and convertible bond financing. The deal encompassed an USD 13 m royalty monetization financing with R-Bridge, an affiliate of Singapore-based healthcare-focused investment firm CBC Group.
Orrick has confirmed to legalcommunity.ch that it will wind down its Geneva office – the only Swiss location – by year-end, following a routine review coinciding with the conclusion of the office lease. The firm also
Swiss workplace management platform Deskbird has recently secured a USD 23 million Series B financing round. Octopus Apollo led the operation, with Neva – the VC alternative asset manager company of the Intesa Sanpaolo Group – as co-lead.
Vischer advised Proteomedix, a Swiss biotech subsidiary of Onconetix, on a licensing agreement with Swedish pancreatic cancer diagnostics company Immunovia. The agreement Under the terms of the agreement, Proteomedix will supply Immunovia with master
